Pharvaris price target maintained at $42 by Wedbush
Wedbush maintained its price target for Pharvaris at $42.00 per share by this Wednesday, according to Benzinga ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.